Emerging treatments
Tedizolid
Data from in vitro studies suggest that tedizolid, a second-generation oxazolidinone antibiotic, has equal or greater efficacy to linezolid, against many Nocardia species.[50][90][91][92] Additionally, it may be less likely to cause toxicity when compared to long-term treatment with linezolid. However, further studies are needed to establish its use as a treatment option.
Use of this content is subject to our disclaimer